Povidone and Crospovidone9003-39-8

Povidone and Crospovidone9003-39-8

Povidone-iodine betadine is yellow-brown to red-brown amorphous powder, soluble in water or ethanol, insoluble in ether or chloroform. Side effects include skin irritation. If applied to large wounds, poor renal function may cause hypernatremia and metabolic acidosis. It is not recommended for people who are pregnant for less than 32 weeks or who take lithium salts. People with thyroid problems are advised not to use it frequently. Povidone iodine is a chemical polymer of povidone and element iodine. It contains 9% to 12% iodine. Its mechanism of action is the death of microorganisms caused by the release of iodine. Povidone-iodine is an over-the-counter medicine.
Send Inquiry
Product Introduction
Traits:

Povidone and Crospovidone9003-39-8** (CAS 9003-39-8) are complementary polyvinylpyrrolidone polymers. Povidone (K30) acts as binder/solubilizer; crosslinked Crospovidone functions as superdisintegrant. Pharmacopeial grades (USP/Ph.Eur) for solid dosage optimization.
 

Povidone-iodine betadine is yellow-brown to red-brown amorphous powder, soluble in water or ethanol, insoluble in ether or chloroform.

Side effects include skin irritation. If applied to large wounds, poor renal function may cause hypernatremia and metabolic acidosis. It is not recommended for people who are pregnant for less than 32 weeks or who take lithium salts. People with thyroid problems are advised not to use it frequently. Povidone iodine is a chemical polymer of povidone and element iodine. It contains 9% to 12% iodine. Its mechanism of action is the death of microorganisms caused by the release of iodine. Povidone-iodine is an over-the-counter medicine.

 

Pharmacopoeia standards:

 

1.Main active ingredients

Complex of 1-vinyl-2-pyrrolidone homopolymer and iodine. Calculated as dry product, the content of available iodine (I) should be 9.0% to 12.0%.

2.Traits:

Yellow-brown to red-brown amorphous powder. It is soluble in water or ethanol, but insoluble in ether or chloroform.

3.Identify:

Take about 0.5g of this product, add 5ml of water to dissolve, and test according to the following method.

(1) Take 1 drop of the solution, add 9ml of water and 1ml of starch indicator solution, it will appear dark blue.

(2) Take 0.5ml of the solution, spread it on a glass plate with an area of about 7.5cm×2.6cm, and place it overnight at low humidity and room temperature to dry, forming a brown, dry film that is easily soluble in water.

Synergistic Applications

 

Povidone and Crospovidone9003-39-8** enable:

►Instant-release tablets: Povidone binds + Crospovidone disintegrates (<30 sec)

►Bioavailability enhancement: Povidone solubilizes BCS II/IV APIs; Crospovidone accelerates dissolution

►Melt extrusion: Povidone forms solid dispersions; Crospovidone prevents gelling

►Direct compression: Dual-action system reduces excipient count

►Stabilization: Povidone inhibits crystallization; Crospovidone absorbs moisture

 

Application:

 

Povidone-iodine

CP2005/USP26

USP31

EP6.0

Appearance

Brown-red or yellow-brown amorphous powder

available iodine %

9.0-12.0

9.0-12.0

9.0-12.0

max iodine ions %

6.6

6.6

6.0

heavy metal ppm max

20

10

--

sulfate ash %max,

0.1

0.025

0.1

nitrogen content

9.5-11.5

9.5-11.5

pH value (10% aqueous solution),

--

 

1.5-5.0

weight loss on drying %max

8.0

8.0

8.0

 

 
 
productioSpecifications
Products name

Povidone K30

Products name

Crospovidone

CAS No

9003-39-8

CAS No

9003-39-8

K-value

27.0–32.4

Swelling Capacity

550–650% (0.1N HCl)

Residual NVP

≤100 ppm (GC)

Particle Size

90% <100μm

Viscosity

3.5–7.5 mPa·s (5% sol)

Water Uptake

≥5.0 ml/g

 

Formulation Protocol

 

1. Binder-Disintegrant Ratio: 1:0.3–1:1 (Povidone:Crospovidone)

2. Wet Granulation: Povidone in binder solution; Crospovidone extragranular

3. Direct Compression: Premix with API; max 0.8% MgSt lubrication

4. Incompatibilities: Avoid peroxides/alkaline glidants
 

Supply Advantages for Povidone and Crospovidone9003-39-8

 

◣GMP Compliance:** EDQM CEP for both polymers

◣Batch Traceability:** Paired COAs with matched expiry dates

◣Synergy Data:** Pre-formulated compatibility reports (DSC/XRD)

◣Bulk Packaging:** 25kg drums (nitrogen flushed for both)

◣Scale Flexibility:** 10kg samples to 20 MT production
 

Critical Processing Notes

 

⊿Povidone Solution Prep: Max 60°C aqueous temperature

⊿Crospovidone Activation: Mill before blending (maintain RH <55%)

⊿Tablet Compression: ≤15 kN force for Crospovidone-containing blends

⊿Stability: 36-month shelf life (<25°C/60% RH both)

 

Failure Mode Mitigation

 

 

☉Sticking: Add 1–2% colloidal SiO₂ when Povidone >10%

☉Capping: Limit Crospovidone to 8% w/w in high-dose tablets

☉Dissolution Failure: Control Crospovidone particle size distribution

 

01

02

03

04

05

06

Hot Tags: Povidone and Crospovidone9003-39-8, China Povidone and Crospovidone9003-39-8 manufacturers, suppliers, factory, Pvp K30 And Pvp K90, Pvp K30 Powder, N Vinylpyrrolidone Synthesis, Pvp K60, PVP K 30 Powder, Povidone Iodine Solution Chemicals

Send Inquiry

Home

Phone

E-mail

Inquiry